Clinical Trial Update: Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating gemcitabine plus leflunomide for advanced unresectable pancreatic cancer is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• ARAVA (leflunomide)
• Gemzar (gemcitabine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 | Phase 1 | Status: RECRUITING